Cannabis terapeutica
Il paziente in vista Sistema endocannabinoide
Accesso alla cannabis medica
Operatori sanitari

HCPs:

Apotheker:innen Avextra THC/CBD-Schnelltest Ärzt:innen

Argomenti:

Studien Indikationen Extrakte und Dronabinol Forschung u. Entwicklung

Servizio:

Fachliteratur Veranstaltungen und Events Media Center Copeia
Su Avextra
Studien Controllo dell’intera filiera Qualità, Made in Germany
Squadra Carriera
Media
Investor Relations Comunicati stampa Videos
Prodotti
Contatti
Lingua
Deutsch English Italiano

Homepage » Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development

Bensheim, Germany, 20 June 2024 – The leading European manufacturer and developer of Cannabis-based medicines Avextra AG (“Avextra”), is proud to announce a strategic partnership in drug development with SynQube GmbH based in Offenbach, Germany. SynQube GmbH is led by the founders of THC Pharm Christian Steup and Holger Rönitz, both pioneers in cannabinoid therapy in Europe with over 25 years of experience in pharmaceutical development and manufacturing of cannabinoid and other psychotropic substances.

Read more

IT
DE EN IT